The Weight Loss Stack
Transform Your Body and Support Sustainable Weight Loss From Within
The Weight Loss Stack combines incretin-based therapies, metabolic peptides, growth hormone secretagogues, and cellular metabolic support designed to support meaningful, sustainable weight loss, appetite regulation, metabolic health, and healthier body composition.
GLP-2 or GLP-1 + Cagrilintide + MOTS-c + CJC/Ipa/Tesa + Fat Blitz · From $734.13 · Full refund if not approved
How It Works
Three Simple Steps
Start Your Stack
Choose GLP-2 or GLP-1 and get the full metabolic support stack built around it.
Provider Review
A licensed provider reviews your health history and sets your dosing. If it isn’t approved, you receive a full refund automatically.
Delivered to Your Door
Your stack is prepared by a licensed compounding pharmacy and shipped 2-Day Air with clear instructions.
What’s Included
Six Targeted Components
Whether your goal is significant fat reduction, breaking through a plateau, improving metabolic markers, or a lasting transformation, this stack is designed to address the multiple biological pathways that drive weight gain and resist weight loss.
GLP-2
Dual GIP/GLP-1 Receptor Agonist
A dual GIP/GLP-1 receptor agonist that supports appetite reduction, healthy blood sugar regulation, and fat loss.
GLP-1
Incretin Receptor Agonist
An incretin-based therapy designed to reduce appetite, slow gastric emptying, and support healthy blood sugar and weight management.
Cagrilintide
Long-Acting Amylin Analog
A long-acting amylin analog designed to support appetite control, satiety signaling, and complementary weight loss when combined with incretin therapies.
MOTS-c
Mitochondrial-Derived Peptide
A mitochondrial-derived peptide designed to support metabolic regulation, fat metabolism, and insulin sensitivity at the cellular level.
CJC-1295/Ipamorelin/Tesamorelin
Growth Hormone Secretagogue Trio
A growth hormone secretagogue trio designed to support natural growth hormone release, visceral fat reduction, lean muscle preservation, and improved body composition.
Fat Blitz Capsules
SLU-PP-332
An oral exercise mimetic compound designed to support metabolic efficiency, fat utilization, and endurance capacity at the cellular level.
Get the Stack
The Weight Loss Stack
Sold as a complete stack. Choose your GLP and your stack size, and everything else comes with it.
What’s in your stack
View the full product page
Sold as a complete stack · Reviewed by a licensed provider · Full refund if not approved · Free shipping over $200
The Ingredients
Get to Know Your Peptides
GLP-2
Dual GIP/GLP-1 Receptor Agonist
A dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It activates both incretin pathways at once, with effects on appetite, blood sugar regulation, and body weight.
Potential benefits include
- Supports meaningful, sustained weight loss
- Activates both GIP and GLP-1 receptors
- Reduces appetite and food intake through central satiety signaling
- Slows gastric emptying to promote longer fullness after meals
- Supports healthy blood sugar control and insulin sensitivity
- May support cardiovascular and metabolic markers
GLP-1
Incretin Receptor Agonist
GLP-1 receptor agonists mimic the action of the naturally occurring incretin hormone GLP-1, which is released from the gut in response to food. These therapies have become a cornerstone of modern weight management.
Potential benefits include
- Reduces appetite and caloric intake through satiety pathways
- Slows gastric emptying to promote sustained fullness
- Supports healthy blood sugar regulation and insulin secretion
- Supports meaningful, sustained weight loss
- May support cardiovascular and cardiometabolic health
- Supports long-term weight management alongside lifestyle changes
Cagrilintide
Long-Acting Amylin Analog
Cagrilintide is a long-acting analog of amylin, a hormone released alongside insulin that helps signal fullness. It engages a different appetite pathway than incretin therapies.
Potential benefits include
- Supports appetite control and satiety signaling
- Engages the amylin pathway, distinct from GIP and GLP-1
- Designed to complement incretin therapies for additional appetite support
- Supports complementary weight loss in a combined protocol
MOTS-c
Mitochondrial-Derived Peptide
MOTS-c is a mitochondrial-derived peptide that plays a role in metabolic regulation and cellular stress response.
Potential benefits include
- Supports metabolic health and insulin sensitivity
- Supports healthy fat metabolism and body composition
- Supports exercise capacity and physical endurance
- Supports cellular stress resistance and metabolic flexibility
- Supports healthy aging at the mitochondrial level
- May support resilience against metabolic fatigue and weight loss resistance
- Complements incretin therapies by supporting metabolism at the cellular level
CJC-1295
GHRH Analog
CJC-1295 is a synthetic peptide analog of growth hormone releasing hormone (GHRH) designed to extend the half-life of natural GHRH signaling.
Potential benefits include
- Supports sustained, pulsatile growth hormone release
- Supports lean body composition and muscle preservation during weight loss
- Supports tissue repair and recovery
- Supports deeper, more restorative sleep
- Supports healthy metabolism and fat utilization
- May support recovery time and training capacity
Ipamorelin
Selective GH Secretagogue
Ipamorelin is a selective growth hormone secretagogue that stimulates the pituitary gland to release growth hormone, studied for minimal effects on cortisol or prolactin.
Potential benefits include
- Targeted, controlled growth hormone release
- Supports muscle recovery and lean tissue during a caloric deficit
- Supports healthy bone density
- Supports improved sleep quality
- Supports regenerative processes
Tesamorelin
GHRH Analog
Tesamorelin is a synthetic growth hormone releasing hormone (GHRH) analog that stimulates the pituitary gland to produce and release growth hormone. It has been studied for its effects on visceral abdominal fat.
Potential benefits include
- Supports reduction of visceral adipose tissue (deep abdominal fat)
- Supports healthier body composition and waist circumference
- Supports natural growth hormone production without suppressing the body’s own axis
- May support lipid profiles and metabolic markers
- Supports lean muscle preservation during weight loss
SLU-PP-332
ERRα Agonist · Exercise Mimetic
SLU-PP-332 is a small-molecule ERRα (estrogen-related receptor alpha) agonist studied as an exercise mimetic. Delivered in convenient oral capsule form as Fat Blitz Capsules.
Potential benefits include
- Supports endurance and exercise capacity at the cellular level
- Supports mitochondrial biogenesis and oxidative metabolism
- Supports fatigue resistance during physical activity
- Supports fat utilization as a fuel source
- May complement training adaptations and body composition changes
- Supports metabolic efficiency throughout the day
Who It’s For
Built for Lasting Results
The Weight Loss Stack is designed for adults working with a provider on weight management, as part of a lifestyle that includes proper nutrition, regular activity, hydration, quality sleep, and behavioral strategies.
- You want meaningful, sustainable weight loss
- You’ve hit a weight loss plateau
- You want to keep lean muscle while losing fat
- You want to support your metabolic health long term
Six pathways. One protocol.
Appetite, metabolism, and lean muscle support together, with a licensed provider reviewing every order.
The Science
How the Stack Works
Each component targets a different aspect of weight loss and metabolic health:
Potential Benefits
The Weight Loss Stack May Help Support
- Meaningful, sustained weight loss
- Appetite control and enhanced satiety
- Reduction of visceral (abdominal) fat
- Lean muscle preservation during a caloric deficit
- Healthy blood sugar control and insulin sensitivity
- Healthier lipid profiles and metabolic markers
- Metabolic efficiency and fat utilization
- Improved body composition and waist circumference
- Fewer food cravings
- Steadier energy and less metabolic fatigue
- Better sleep quality and restorative rest
- Body confidence
Individual results vary and are influenced by starting weight, metabolic health, nutrition, physical activity, sleep, and adherence to the prescribed treatment plan.
Your Protocol
Recommended Usage
Your provider sets your exact dosing and titration schedule. Here’s how the stack typically fits into your week.
GLP-2 with B12
- Inject subcutaneously once weekly as directed by your provider
- Begin at the lowest prescribed dose and titrate gradually
- Rotate injection sites (abdomen, thigh, or upper arm)
GLP-1 with B12
- Inject subcutaneously once weekly as directed by your provider
- Begin at the lowest prescribed dose and titrate gradually
- Rotate injection sites (abdomen, thigh, or upper arm)
Cagrilintide
- Inject subcutaneously once weekly as directed by your provider
- Begin at the lowest prescribed dose and titrate gradually
- Follow all dose escalation schedules from your clinician
MOTS-c
- Subcutaneous injection with your pen injector
- Typically every 3 days
- Your dose is set by your provider
CJC-1295/Ipamorelin/Tesamorelin
- Inject at bedtime on an empty stomach (no food for at least 3 hours)
- Example: Monday through Friday inject, Saturday and Sunday rest
- Your dose is set by your provider
Fat Blitz Capsules
- Typically 1 to 2 capsules daily
- Take in the morning or 30 to 60 minutes before physical activity
- Consistency is key: daily use supports sustained benefits
Do not adjust doses of GLP-2, GLP-1, or Cagrilintide without direct guidance from your healthcare provider. Continue all protocols unless otherwise directed.
Daily Habits
Building a Complete Weight Loss Routine
For best results, combine your protocol with healthy daily habits.
Morning
- Hydrate immediately upon waking
- Take your Fat Blitz Capsules as directed
- Eat a protein-forward breakfast (30 to 40g) to support satiety and lean muscle
- Structured exercise or a morning walk
Midday
- A nutrient-dense meal with lean protein, fiber-rich vegetables, and healthy fats
- Stay well hydrated throughout the day
- A short walk after meals to support blood sugar
- Mindful eating: slow down, minimize distractions, and listen to fullness cues
Weekly
- GLP-2 or GLP-1 injection on your designated day
- Cagrilintide injection on your designated day
- Track weight, measurements, and progress photos weekly
- Review nutrition and activity with your provider
Free Download
The Weight Loss Stack Guide
Everything in one place: each component explained, your weekly schedule, and a complete daily routine for lasting results. Save it, share it, or bring it to your provider.
What to Expect
Your Timeline
Weeks 2 to 4
Many people notice reduced appetite and early changes, particularly with GLP-2 or GLP-1 therapy.
Weeks 8 to 16
Body composition changes typically become more apparent with consistent use, nutrition, and activity.
Several Months
Continued progress may develop as your provider optimizes doses and your metabolism adapts.
This advanced protocol is intended to complement a comprehensive weight management lifestyle that includes proper nutrition, regular physical activity, hydration, quality sleep, behavioral strategies, and provider-guided care.
About LaviMD
Our Story
LaviMD is a physician-founded longevity and anti-aging brand dedicated to helping people look, feel, and age better through science-backed therapies.
Founded by Dr. Sasson E. Moulavi, a board-certified physician with more than 30 years of clinical experience, LaviMD combines advanced peptide therapies with evidence-based medicine to support healthy aging, skin health, recovery, and overall wellness.
As LaviMD’s founder, Dr. Sass continues to lead with a commitment to innovation, patient care, and delivering therapies rooted in science.
FAQ
Frequently Asked Questions
Your choice of GLP-2 or GLP-1, plus Cagrilintide, MOTS-c, CJC-1295/Ipamorelin/Tesamorelin, Fat Blitz Capsules (SLU-PP-332), a NEST injection pen, and pen needles, in 1, 2, or 4 vial sizes at 10%, 20%, or 40% off. Your provider determines which combination is most appropriate for you.
Yes. Every order is reviewed by a licensed provider before fulfillment. If your provider determines the protocol isn’t appropriate for you, you receive a full refund automatically, with no return needed.
Individual responses vary. Many people notice reduced appetite within the first few weeks, particularly with GLP-2 or GLP-1 therapy. Body composition changes typically become more apparent over 8 to 16 weeks of consistent use combined with proper nutrition and physical activity, and may continue over several months as doses are optimized.
Results are highly individual and depend on starting weight, metabolic health, adherence to nutrition and exercise recommendations, and the specific combination of therapies prescribed. Your provider will set realistic, personalized goals based on your profile.
Most people experience reduced hunger and fewer food cravings, particularly as incretin and amylin-based therapies reach their prescribed doses. It remains important to eat adequate protein and nutrient-dense foods to support lean muscle and overall health.
GLP-2, GLP-1, and Cagrilintide each target distinct hormonal pathways involved in appetite and satiety: GIP, GLP-1, and amylin. Engaging more than one pathway may support more robust appetite control than a single pathway alone. Your provider determines which combination is right for you.
The CJC-1295/Ipamorelin/Tesamorelin combination is included to support growth hormone release and lean muscle preservation during weight loss. Combined with adequate protein (a common target is about 1 gram per pound of goal body weight daily) and regular resistance training, this approach helps minimize muscle loss.
Yes. For the best growth hormone response, inject on an empty stomach, ideally with no food for at least 3 hours beforehand. Most people take it at bedtime.
The most common side effects of incretin-based therapies (GLP-2, GLP-1) include nausea, vomiting, diarrhea, constipation, and decreased appetite, particularly while doses are being increased. These are typically mild to moderate and often improve over time. Injections may cause mild redness or bruising at the site. Your provider will manage your dose titration to minimize side effects.
These products may not be appropriate during pregnancy or breastfeeding; for anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2); for anyone with a history of pancreatitis, active cancer, or certain other medical conditions; or for those taking specific medications. Growth hormone secretagogues require particular caution in anyone with a history of malignancy. Always discuss your complete medical history with your provider.
Ready to Transform Your Body and Support Lasting Weight Loss?
Sustainable weight loss begins with a comprehensive approach that combines science-backed therapies, proper nutrition, regular physical activity, quality sleep, behavioral strategies, and provider-guided protocols.
Important Safety Information
This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Prescription products require evaluation and approval by a licensed provider. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Do not use if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), if you have a history of pancreatitis, or if you are pregnant or breastfeeding. Common side effects of incretin-based therapies include nausea, vomiting, diarrhea, and constipation. Follow all dosing instructions provided by your prescribing clinician, and do not adjust doses of GLP-2, GLP-1, or Cagrilintide without direct guidance from your healthcare provider. Individual results vary.